Translating tolerogenic therapies to the clinic - Where do we stand and what are the barriers?

Stephen P. Cobbold, Xian C. Li

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Article number	Article 317
Journal	Frontiers in immunology
Volume	3
Issue number	OCT
DOIs	https://doi.org/10.3389/fimmu.2012.00317
State	Published - 2012

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.3389/fimmu.2012.00317

Other files and links

Link to publication in Scopus

Cite this

@article{5a7979f08753456eb8f8126d2f75f1ca,

title = "Translating tolerogenic therapies to the clinic - Where do we stand and what are the barriers?",

author = "Cobbold, {Stephen P.} and Li, {Xian C.}",

year = "2012",

doi = "10.3389/fimmu.2012.00317",

language = "English (US)",

volume = "3",

journal = "Frontiers in immunology",

issn = "1664-3224",

publisher = "Frontiers Media S. A.",

number = "OCT",

}

TY - JOUR

T1 - Translating tolerogenic therapies to the clinic - Where do we stand and what are the barriers?

AU - Cobbold, Stephen P.

AU - Li, Xian C.

PY - 2012

Y1 - 2012

UR - http://www.scopus.com/inward/record.url?scp=84874221508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874221508&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2012.00317

DO - 10.3389/fimmu.2012.00317

M3 - Editorial

C2 - 23091475

AN - SCOPUS:84874221508

SN - 1664-3224

VL - 3

JO - Frontiers in immunology

JF - Frontiers in immunology

IS - OCT

M1 - Article 317

ER -